Search Results

Aberrant EBI2 signaling is implicated in inflammatory bowel disease, sclerosis, and infectious disease oxysterol ligand and will facilitate the development of therapeutic approaches that target EBI2-linked diseases

Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease GPCRs arguably represent the most effective current therapeutic targets for a plethora of diseases. The molecular diversity of GPCR signaling systems is likely to be closely associated with disease-associated complexity and compartmentalization, thus enabling a nuanced GPCR-based capacity to interdict multiple disease cellular activities implicates them as key controllers of the functional balance between health and disease

This high-resolution mapping can confirm the protein’s role in disease pathology and highlight allosteric Resistance A significant challenge in drug development, particularly in the treatment of infectious diseases The choice of model systems, such as yeast, bacteria, or mammalian cells, can heavily influence the method's systems, including multicellular organisms and human cells, to better mimic physiological conditions and disease BioRxiv (Cold Spring Harbor Laboratory) . https://doi.org/10.1101/2024.04.17.590000 Pines, G., Fankhauser

Join the global GPCR community to share your research—submit your abstract using this form. knockdown regulates the expression and alternative splicing of genes associated with aphasia-related diseases neuropeptide and neurotransmitter release GPCRs in Oncology and Immunology Neurotoxicity and accumulation of CPPD ochraceus quorum sensing through the GprC-AcyA pathway Deciphering the genetic landscape of lumpy skin disease

The activation of mTOR complex 1 (mTORC1) is typically observed in human disease and continues to be Understanding the upstream regulators of mTORC1 will provide a crucial link to targeting mTORC1 hyperactivated diseases Statement mTORC1 is a master regulator of many cellular processes and is often hyperactivated in human disease molecular underpinnings of these pathways will undoubtedly be promising to the mTORC1 field and human disease

protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents to treat Parkinson's disease X-ray crystallographic structures of 2 in complex with two thermostabilized A2AAR constructs were solved

Investigational LPA1 Antagonist Reduces the Rate of Lung Function Decline in Patients with Idiopathic Pulmonary

s Phase 1 study of CRN04894, the company’s investigational candidate for the treatment of Cushing’s disease both serum cortisol levels and 24-hour urine free cortisol excretion in the presence of sustained, disease-like

Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases seven-transmembrane G-protein-coupled receptor (GPCR) involved in various pathologies, in particular autoimmune diseases

coupled receptors (GPCRs) for galanin have been discovered, which is the focus of efforts to treat diseases including Alzheimer’s disease, anxiety, and addiction.

September 2022 "Systemic sclerosis (SSc) is a systemic autoimmune disease with the key features of inflammation Extracellular vesicles are another novel player to possess disease processes.

mechanistic computational approach that couples drug pharmacokinetics/pharmacodynamics and the course of disease It has begun to play important roles in drug development for complex diseases such as cancer, including

September 2022 "G protein‐coupled receptors (GPCRs) are valuable therapeutic targets for many diseases The interpretation of ML analysis in human understandable form allowed us to construct an exquisitely

Finally, we briefly discuss the therapeutic targeting of vGPCRs as future treatment of acute and chronic

August 2022 "Abstract Rodent models are commonly used to evaluate parathyroid hormone (PTH) and PTH-related ) ligands and analogues for their pharmacologic activities and potential therapeutic utility toward diseases

international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases

The sheer complexity of the cell and the astonishing diversity of diseases are just two reasons why researchers typically require years to uncover the mechanisms of disease before they can even dare to contemplate

November 2021 "Chronic use of most opioids causes tolerance; the new compounds avoid this and other unwanted

important drug targets, and numerous drugs that modulate GPCRs are already in clinical use for various diseases framework which involves three stages: 1) feature extraction or pattern identification; 2) vector space construction Drug repurposing: AI algorithms can screen existing drugs and repurpose them for GPCR-related diseases By analyzing drug-target interactions and disease pathways, AI can identify potential candidates that Towards a comprehensive understanding of GPCRs, ligands, diseases, and their associations: open-access

GPCR-Mediated Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Disease s Activation of GPR55 alleviates neuropathic pain and chronic inflammation Developmental exposures to

Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease The prevalence of non-alcoholic fatty liver disease (NAFLD) is globally increasing. Gaining control over disease-related events in non-alcoholic steatohepatitis (NASH), an advanced form

cellulose-degrading enzymes Functional Water Channels Within the TSH Receptor - a new paradigm for TSH action with disease multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases

exclusive rights to develop its own independent GABAB PAM program, have also been expanded to include chronic

Repurposing Vaptans "Men with advanced prostate cancer are treated by androgen deprivation therapy but the disease cancer patient sample data revealed that coexpression of AVPR1A and AVPR2 is highly correlated with disease

August 2022 "Aims: The pathophysiological mechanism(s) underlying non-alcoholic fatty liver disease (

receptor (GPCR) GPR35 is involved in oncogenic signaling, bacterial infections, and inflammatory bowel disease transducer interactions and allow for mechanism-based therapies against, for example, inflammatory bowel disease

want to present a poster, all you have to do is fill out the submission form and submit a 1-minute abstract Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study

CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases